Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ContextVision - invitation to company presentation

We are pleased to invite you to a shareholder presentation of Contextvision AB and its 4[th] quarter and full year 2020 figures and give an update on the company’s development and ongoing projects. The presentation will be held as an online webinar, hosted by SpareBank 1 Markets.  Tuesday, February 23[rd] at 12:30 – 13:15 We are very proud of Context Vision’s developments during 2020 and look forward to sharing an update of the achievements. Fredrik Palm, CEO, and Ann-Charlotte Linderoth, CFO, will represent the management. There will be time for questions after the presentation. You

Minutes of the Monetary Policy Meeting held on 9 February 2021

At the Monetary Policy Meeting on 9 February, the Executive Board of the Riksbank decided to hold the repo rate unchanged at zero per cent. To provide support to the recovery and inflation, the Riksbank is also continuing to purchase assets within the envelope of SEK 700 billion and to offer liquidity within all the programmes launched in 2020.The second wave of infection during the autumn and winter has led to tightened restrictions and a slowdown in the recovery of the global economy. However, the board members noted that the Swedish economy has been more resilient to the second wave of

Why was Conotoxia a new home for Forex services for so many in 2020?

Closing the year 2020 with a successive increase in turnover, revenue and number of transactions, new products offered to clients and powerful analyses and educational zone are just a few to name for Conotoxia Ltd. The company shined; its demand for Forex services grew incredibly fast, and it aims at even further strong growth, thanks to, among others, LMAX Global offering its Polish customers to transfer their accounts to Conotoxia Ltd.Back in December 2017, Conotoxia Ltd. launched Forex services for users of the portal found at Cinkciarz.pl or Conotoxia.com, which also provides access to

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 44 - 19 FEBRUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Cell Impact reports fourth quarter results for 2020

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the fourth quarter.· Revenues for the quarter totaled SEK 8.9 million (2.0). Total revenues up to and including the fourth quarter amounted to SEK 29.3 million (11.9), which is a growth of 146 percent for the entire year. · Operating result was SEK -12.3 million during the quarter (-16.9). Total operating result was SEK -43.1 million for the full year up to and including the fourth quarter (-47.4). · The Group's result after financial items was SEK -12.5 million (-17.0) during the quarter. ·

Your absent-mindedness is business as usual, shows new research

Are you often absent-minded, feeling that your thoughts are meandering away unpredictably? Now there is a scientific explanation. New research from Lund University and RISE, Research Institutes of Sweden, in Sweden shows that the brain’s nerve cells are completely reliable—in their unreliability. This is revealed by a new mathematical method and experimental measurements.-    The findings are significant for our fundamental grasp of the brain’s function, which is important not only for understanding disorders of the brain, but also for the growth of AI technology and machine learning which

TOMRA: New reporting segments key figures spreadsheet

To provide better transparency and reflecting the Food segments has become a significant part of the Group, TOMRA announced on October 22, 2020, that it will expand from two reporting segments to three. The change applies as of fourth quarter 2020, and consequently the annual report and fourth quarter 2020 will be reported in the new format. To ensure comparability, TOMRA restates the 2019 key figures according to the new structure. The spreadsheet is available on https://www.tomra.com/en/investor-relations/financial-information/key-figures. Asker, 19 February 2021 TOMRA Systems

Assemblin launches unique solution to simplify transition to a fossil-free vehicle fleet

With its complete solution Assemblin Charge, Assemblin is taking the lead in the development of smart, sustainable services for charging infrastructure and contributing to the transition to a fossil-free society. The solution combines installation and servicing of charging points with a unique cloud-based administration platform.The demand for smart solutions for electric car charging is rapidly growing among private individuals, housing associations, property owners and companies. Assemblin, one of the Nordic region’s leading installation companies, is one of the players that can support

Year-End Report 2020

Strong earnings and new acquisitions Håkan Lind, CEO of Bellman Group comment: “The last quarter of the year has been characterized by acquisitions and refinancing of Bellman Group. We acquired both Losshållningsbolaget (LHB) with operations in the quarrying and civil engineering sector and a land area in the Gothenburg region which in the future can be developed into a landfill. We also signed an agreement to acquire Ivarssons, an excavation and civil engineering company mainly operating in the Gothenburg region. The refinancing resulted in issuance of a corporate bonds of SEK 900

Relais will publish its Financial Statements Bulletin 2020 on February 25, 2021 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release 19 February 2021 at 10:00 a.m. EET  Relais Group Plc will publish its Financial Statements Bulletin 2020 on Thursday, February 25, 2021 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on February 25, 2021, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Pekka Raatikainen will host the event. The webcast can be followed at https://relais.videosync.fi/2021-02-25-

Notice of extra general meeting in Senzime AB (publ)

Press release: Uppsala, February 19, 2021. The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the “Company”) are hereby convened to an extra general meeting on Friday 5 March 2021 in Uppsala.Right to attend the extra general meeting Due to the corona pandemic and in order to  ensure the health and safety of shareholders, employees and other stakeholders, the board of directors in Senzime has resolved that the shareholders in Senzime may not attend to the general meeting in person nor to be represented by proxy and that no other person may attend to the general meeting in

Year-end Report 1 October – 31 December 2020

“Today, we have announced the intention of filing a 510(k) application to the US FDA during 2021 for market approval for an Episealer® Patellofemoral System. This is an expansion of the clinical indications for using the Episealer® knee implants”, says Pål Ryfors, CEO Episurf Medical. Fourth quarter 2020 compared to 2019, Group · Gross order intake amounted to SEK 1.3m (1.2), an increase of 9%. We experienced a 21% increase in orders for Episealer® implants during the quarter with 57 (47) approved orders. Compared to Q3 2020, we experienced a decrease in the gross order intake as

Year-End Report 2020

ChromoGenics conducted a fully guaranteed rights issue for accelerated growthQ4 2020 · ChromoGenics continued to be impacted during the quarter by the coronavirus pandemic and delays in adjustments to the sputter machines, which resulted in delayed orders from the company’s customers. Order intake and invoicing were pushed back in 2020 and into 2021. Several customers are waiting until we can deliver dynamic glass with film produced in house before they place their orders. · In the fourth quarter, order intake amounted to SEK 6.0 (3.1) million, an increase of 93 percent compared to

NENT Group to launch ‘Kin’ as its next Viaplay Original

· Star-studded cast with Charlie Cox (‘Boardwalk Empire’), Clare Dunne (‘Herself’) and Aidan Gillen (‘Game of Thrones’) in leading roles · ‘Kin’ is produced by BRON Studios and Headline Pictures · NENT Group to premiere at least 40 original productions in 2021 Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company will premiere drama series ‘Kin’ as its next Viaplay Original. The eight episode long series sees Charlie Cox (‘Boardwalk Empire’), Clare Dunne (‘Herself’) and BAFTA nominated actor Aidan Gillen (‘Game of Thrones’) in the leading roles and

Payment of share rewards based on the share-based incentive programme as a directed share issue of own shares of the company without consideration

Pihlajalinna Plc                   Stock Exchange Release     19 February 2021 at 9.30 a.m. Payment of share rewards based on the share-based incentive programme as a directed share issue of own shares of the company without consideration On 19 February 2021, the Board of Directors of Pihlajalinna Plc has confirmed the maximum number of performance-based additional shares, 56,583 shares, earned based on the earning period 2020 of the share-based incentive programme which commenced in 2019 for the company's key personnel and resolved on the payment of the share rewards earned based on

Eurocine Vaccines publishes half-year report for July-December 2020

Eurocine Vaccines AB (“Eurocine Vaccines”) hereby publishes an interim report for the first half year of 2020. Below is a summary of the report. The full report is available on the Euroccine Vaccines website and as an attachment.2020-07-01– 2020-12-31 (first half year) · Result after tax during the first half year amounted to -7,6 MSEK (-4,7 MSEK) · Revenues during the half year amounted to 0,4 MSEK (0 MSEK) · Earnings per share the half year -0,01 SEK (-0,03 SEK) CEO Hans Arwidsson comments “It has been an incredibly exciting period for

Crunchfish enrolled to VISA Technology Partner program

Crunchfish AB (“Crunchfish”) announces its enrolment into VISA Technology Partner program with its Digital Cash solutions. As a VISA technology partner, Crunchfish will get access to VISA specifications and toolkits enabling potential integration with the VISA digital payment rail. Crunchfish’s patent pending Digital Cash solutions are built on a two-tier offline vs. online settlement architecture. As a VISA Technology Partner, Crunchfish will get access to VISA specifications and toolkits enabling Digital Cash development, evaluation and potential integration with the VISA

INITIATOR PHARMA: YEAR END REPORT 2020

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Fourth Quarter (2020-10-01 – 2020-12-31) · Net revenues were TDKK 0 (0) · Operating loss, EBIT was TDKK -2,069 (-2,503) · Earnings per share was DKK –0.01 (-0.06) Full Year (2020-01-01 – 2020-12-31) · Net revenues were TDKK 0 (0) · Operating loss, EBIT was TDKK -10,531 (-9,339) · Earnings per share was DKK –0.32 (-0.34) · Cash and bank: TDKK 13,504 (7,562) · Solidity: 92% (87%) Group earnings per share:

Heliospectra AB (publ) Year End Report 2020

(Gothenburg, Sweden, February 19, 2021) – Heliospectra AB (publ) (OTCQB: HLSPY, First North Growth Market: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents Year End Report 2020.Summary Year End Report 2020 SALES AND FINANCIAL PERFORMANCE, OCTOBER – DECEMBER Net sales amounted to KSEK 11,296 (2,784). The operating loss amounted to KSEK -9,481 (-18,502) KSEK, signifying a negative operating margin (neg). The loss after tax was KSEK -9,485 (-18,514). Orders during the period amounted to KSEK 9,440. SALES AND

Acting CFO

As previously announced, the current CFO, Claes Engvall, will leave his position in May 2021. Recruitment for a replacement is ongoing. As of May 17, Anette Lundh will take on the role as acting CFO. She has extensive experience as CFO from industrial companies and has worked for Studsvik on a consultancy basis. For more information please contact: Camilla Hoflund, President and CEO, +46 155 22 10 66   Facts about Studsvik Studsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik's business focus areas are fuel and materials

GJF: Capital Markets Day 24 November 2021 - save the date

Gjensidige Forsikring will host a virtual Capital Markets Day for investors and analysts on 24 November 2021. The event will start at 09:00 CET.  Additional details, including agenda and registration for virtual participation, will be sent out closer to the date of the event. Contact person Gjensidige Forsikring ASA: Head of Investor Relations: Mitra H. Negård. Tel: +47 957 93 631Investor Relations Officer: Kjetil G. Østvold. Tel: +47 468 63 004

Per Norén appointed new CEO at Ovzon

Inside information: Ovzon's Board of Directors has today appointed Per Norén as the CEO of Ovzon AB effective latest May 1 2021. The company’s current CEO Magnus René will continue to lead the company until then and will thereafter remain in his role as a member of the Board of Directors.Per Norén has a background from leading Swedish and US technology companies. He most recently served as President of Global Eagle, the satellite and connectivity services provider. Prior to that, he was Vice President at Boeing in Seattle and CEO at Carmen Systems. Carmen Systems was a fast-growing Swedish

Arctic Bioscience AS: NOK 300 million Private Placement successfully placed

Arctic Bioscience is pleased to announce that the Private Placement has successfully been placed.Reference is made to the announcement from Arctic Bioscience AS (“Arctic Bioscience” or the “Company”) published on 16 February 2021 regarding a contemplated Private Placement (as defined below) and admission to trading on Euronext Growth Oslo (the “Admission”). The Company is pleased to announce that the Private Placement (as defined below) has been successfully placed through the allocation of 9,677,419 new shares in the Company (the “New Shares”) at a price of NOK 31.00 per share (the “

There are no items matching the current filter
There are no more items matching the current filter
Back to top